India has raised the issue of pharmaceutical pricing control in Australia, particularly on generic medicines, during a bilateral meeting between the officials of both countries. The two sides have decided to work closely on resolving market access issues, enhancing people-to-people contacts, and establishing an institutional mechanism for sharing preferential import data.
